Knut Breistøl

617 total citations
11 papers, 499 citations indexed

About

Knut Breistøl is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Knut Breistøl has authored 11 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Knut Breistøl's work include Cancer Treatment and Pharmacology (5 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Bone health and treatments (3 papers). Knut Breistøl is often cited by papers focused on Cancer Treatment and Pharmacology (5 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Bone health and treatments (3 papers). Knut Breistøl collaborates with scholars based in Norway, Netherlands and United Kingdom. Knut Breistøl's co-authors include Øystein Fodstad, Øyvind S. Bruland, Roy H. Larsen, Gjermund Henriksen, Hans R. Hendriks, Marit Liland Sandvold, Finn Myhren, Erik De Clercq, Jan Balzarini and Gilberto Schwartsmann and has published in prestigious journals such as Journal of Medicinal Chemistry, European Journal of Cancer and European Journal of Medicinal Chemistry.

In The Last Decade

Knut Breistøl

11 papers receiving 479 citations

Peers

Knut Breistøl
Marlein Miranda Cona Belgium
G. R. Boniface Australia
Hennie M.M. Schlüper Netherlands
Steven M. Schmid United States
Fan Jiang China
Kimihiro Ito Japan
Silvia Marchetti Italy
Haiping Wang China
Anupam Mathur India
Adrianus C. Laan Netherlands
Marlein Miranda Cona Belgium
Knut Breistøl
Citations per year, relative to Knut Breistøl Knut Breistøl (= 1×) peers Marlein Miranda Cona

Countries citing papers authored by Knut Breistøl

Since Specialization
Citations

This map shows the geographic impact of Knut Breistøl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Knut Breistøl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Knut Breistøl more than expected).

Fields of papers citing papers by Knut Breistøl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Knut Breistøl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Knut Breistøl. The network helps show where Knut Breistøl may publish in the future.

Co-authorship network of co-authors of Knut Breistøl

This figure shows the co-authorship network connecting the top 25 collaborators of Knut Breistøl. A scholar is included among the top collaborators of Knut Breistøl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Knut Breistøl. Knut Breistøl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Bergman, Andries M., Catharina M. Kuiper, Paul Noordhuis, et al.. (2004). Antiproliferative Activity and Mechanism of Action of Fatty Acid Derivatives of Gemcitabine in Leukemia and Solid Tumor Cell Lines and in Human Xenografts. Nucleosides Nucleotides & Nucleic Acids. 23(8-9). 1329–1333. 25 indexed citations
2.
Bruheim, Skjalg, Øyvind S. Bruland, Knut Breistøl, Gunhild M. Mælandsmo, & Øystein Fodstad. (2004). Human osteosarcoma xenografts and their sensitivity to chemotherapy. Pathology & Oncology Research. 10(3). 133–141. 36 indexed citations
3.
Årstad, Erik, P. Hoff, Lars Skattebøl, Arne Skretting, & Knut Breistøl. (2003). Studies on the Synthesis and Biological Properties of Non-Carrier-Added [125I and 131I]-Labeled Arylalkylidenebisphosphonates:  Potent Bone-Seekers for Diagnosis and Therapy of Malignant Osseous Lesions. Journal of Medicinal Chemistry. 46(14). 3021–3032. 23 indexed citations
4.
Henriksen, Gjermund, Knut Breistøl, Øyvind S. Bruland, Øystein Fodstad, & Roy H. Larsen. (2002). Significant antitumor effect from bone-seeking, alpha-particle-emitting (223)Ra demonstrated in an experimental skeletal metastases model.. PubMed. 62(11). 3120–5. 215 indexed citations
5.
Breistøl, Knut, Hans R. Hendriks, & Øystein Fodstad. (1999). Superior therapeutic efficacy of N-l-leucyl-doxorubicin versus doxorubicin in human melanoma xenografts correlates with higher tumour concentrations of free drug. European Journal of Cancer. 35(7). 1143–1149. 21 indexed citations
6.
Breistøl, Knut, Jan Balzarini, Marit Liland Sandvold, et al.. (1999). Antitumor activity of P-4055 (elaidic acid-cytarabine) compared to cytarabine in metastatic and s.c. human tumor xenograft models.. PubMed. 59(12). 2944–9. 63 indexed citations
7.
Breistøl, Knut, Hans R. Hendriks, Dan Berger, et al.. (1998). The antitumour activity of the prodrug N-l-leucyl-doxorubicin and its parent compound doxorubicin in human tumour xenografts. European Journal of Cancer. 34(10). 1602–1606. 28 indexed citations
8.
Fodstad, Øystein, et al.. (1996). Comparative antitumor activities of halichondrins and vinblastine against human tumor xenografts.. PubMed. 1(2). 119–25. 24 indexed citations
9.
Hendriks, Hans R., Simon P. Langdon, Dietmar Berger, et al.. (1992). Comparative antitumour activity of vinblastine-isoleucinate and related vinca alkaloids in human tumour xenografts. European Journal of Cancer. 28(4-5). 767–773. 17 indexed citations
10.
11.
Kjønniksen, Inge, Knut Breistøl, & Øystein Fodstad. (1992). Site-dependent differences in sensitivity of LOX human melanoma tumors in nude rats to dacarbazine and mitozolomide, but not to doxorubicin and cisplatin.. PubMed. 52(5). 1347–51. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marlein Miranda Cona Breakdown of academic impact, for papers by G. R. Boniface Breakdown of academic impact, for papers by Hennie M.M. Schlüper Breakdown of academic impact, for papers by Steven M. Schmid Breakdown of academic impact, for papers by Fan Jiang Breakdown of academic impact, for papers by Kimihiro Ito Breakdown of academic impact, for papers by Silvia Marchetti Breakdown of academic impact, for papers by Haiping Wang Breakdown of academic impact, for papers by Anupam Mathur Breakdown of academic impact, for papers by Adrianus C. Laan
Rankless by CCL
2026